CSI Market
Sign In | Register

Aerie Pharmaceuticals Inc (AERI) Quarterly Cash Flow Statement

Quarterly · GAAP · USD millions
Access AERI Annual Cash Flow →
Reviewing cash flow data across recent quarters allows users to assess how Aerie Pharmaceuticals Inc adapts its cash strategy across cycles.
View historic periods: Download as CSV:
Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.
Quarterly Report, GAAP in USD millions
ITEM 		(Sep 30 2022)
9 Months 		(Jun 30 2022) (Mar 31 2022) (Dec 31 2021) (Sep 30 2021)
Operating Activities
Income-82.09
Depreciation & amortization4.80
Amortization of Other Assets5.58
Extraordinary Item, Gain (Loss), Insurance Assets, Accretion Expense0.00
Restructuring & Impairment Charges0.00
Provision For Loan Losses Expensed0.00
Increase (Decrease) in Inventories-5.55
Research and Development in Process0.00
Gain (Loss) on Disposition of Assets0.00
Share-based Compensation12.23
Income (Loss) from Equity Method Investments0.00
Foreign Currency Transaction Loss, before Tax0.00
Amortization Of Debt Discount Premium One-
Induced Conversion Of Convertible Notes-
Increase Decrease In Operating Lease Liability-
Increase Decreasein Operating Lease Liabilities-3.34
Increase Decrease In Licensing Receivable90.00
Income taxes0.00
Losses/ -gains on Investments net0.00
Increase (Decrease) in Accounts Receivable-5.05
Increase (Decrease) in Accounts Payable and Other Operating Liabilities7.69
Increase (Decrease) in Interest Payable, Net0.00
Deferred Revenue and Customer Advances and Deposits0.00
Increase (Decrease) in Prepaid Expense and Other Assets6.94
Other Working Capital0.00
Other Noncash Income (Expense)-0.51
Other net0.00
Payments for (Proceeds from) Other Operating Activities6.57
Discontinued operations0.00
Net Cash flow from Operating Activities37.28
Investing Activities
Capital Expenditures-3.78
Sale of Capital Items0.00
Proceeds from Maturities, Prepayments and Calls of Available-for-sale Securities0.00
Payments to Acquire Available-for-sale Securities, Debt-145.73
Real Estate Investments0.00
Restricted Cash and Investments Increase (Decrease)0.00
Payments for (Proceeds from) Loans0.00
Payments for (Proceeds from) Deposits0.00
Proceeds from Sale, Maturity and Collection of Investments129.14
Payments for (Proceeds from) Federal Reserve and FHLB0.00
Acquisition Net of Cash Acquired0.00
Interest in Subsidiaries and Affiliates0.00
Sale of businesses0.00
Accounts payable0.00
Receivables0.00
Payments for (Proceeds from) Other Investing Activities0.00
Other Net0.00
Discontinued operations0.00
Net Cash Flow from Investing Activities-20.37
Financing Activities
Short-term debt Net0.00
Other borrowing transactions0.00
Long-term debt - borrowings0.00
Long-term debt - repayments0.00
Federal Home Loan Bank and Federal Funds0.00
Issuances / -repurchases of Comm. Stock0.00
Partnership and Parent Transactions0.00
Issuances / -repurchases of Pref. Stock0.00
Deposits, Annuities, Contract Holders Funds0.00
Other financing activities net0.00
Other net0.00
Payment For Initial Public Offering Cost-
Proceeds From Exercise Of Stock Purchase Rights-
Payments of Stock Issuance Costs Offering Expenses-
Proceeds Relatedto Issuance of Stock For Stock Based Compensation Arrangementsnet-
Proceeds Relatedto Issuance of Stock For Stock Based Compensation Arrangements Net-
Proceeds Payments Related To Issuance of Stock For Stock Based Compensation Arrangements-
Payments Of Call Options-
Payments Related To Issuance Of Stock For Stock Based Compensation Arrangements0.00
Payments of Dividends, Preferred Stock and Preference Stock0.00
Dividends paid0.00
Net Cash Flow from Financing Activities0.00
Effect of exchange rate on cash flow0.00
Discontinued operations0.00
Free Cash Flow33.50
Total Cash Flow16.91
4 historic quarters locked

Sign in to unlock the full Aerie Pharmaceuticals Inc cash flow history.

Sign In Create Free Account

About Aerie Pharmaceuticals Inc Quarterly Cash Flow Statement

What this statement shows

This page presents issuer-reported cash flow data, including operating, investing, financing, net, and free cash flow, as disclosed in SEC filings and normalized by CSIMarket.

Source & verification

Last updated

  • Page updated:
  • Data lineage: SEC filings - XBRL extraction - normalization in the CSIMarket.com database.
  • Accession: 0001337553-22-000041

Figures are derived from filed reports and may be restated. Historical data is subject to revision.